Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-κB)

Experimental and Molecular Pathology

Volumn 90, Issue 3, 2011, Pages 244-251

  Godek, Jessica ^a   Sargiannidou, Irene ^a,b   Patel, Sneha ^a   Hurd, Lauren ^a   Rothman, Vicki L ^a   Tuszynski, George P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

Angiocidin; Breast cancer; Cytokines; EGFR; Nf B pathway; Proliferation

Indexed keywords

4557 W; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT ANGIOCIDIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN MICROARRAY; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; NF-KAPPA B; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

MUS;

EID: 79951716952     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.01.002     Document Type: Article

References (33)

1. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
2. Biswas D.K., Iglehart J.D. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J. Cell. Physiol. 2006, 209:645-652.
3. Biswas D.K., et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl Acad. Sci. USA 2004, 101:10137-10142.
4. Chang M., et al. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 2009, 10:1089-1095.
5. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
6. Dimitrov S., et al. The endothelial apoptotic activity of angiocidin is dependent on its polyubiquitin binding activity. Br. J. Cancer 2005, 93:662-669.
7. Eubank T.D., et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 2009, 69:2133-2140.
8. Fujimoto H., et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int. J. Cancer 2009, 125:1276-1284.
9. Garay R.P., et al. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. Eur. J. Pharmacol. 2007, 563:1-17.
10. Gaurnier-Hausser A., Tuszynski G.P. The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor. Curr. Pharm. Des. 2009, 15:1937-1948.
11. Gaurnier-Hausser A., et al. The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages. Cancer Res. 2008, 68:5905-5914.
12. Gooch J.L., et al. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ. 2000, 11:335-342.
13. Grant D.S., et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002, 21:4765-4777.
14. Iacopino F., et al. Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines. Int. J. Cancer 1997, 71:1103-1108.
15. Iozzo R.V., et al. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 1999, 274:4489-4492.
16. Johansson E., et al. Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 1997, 41:642-645.
17. Karin M., et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2:301-310.
18. Kremlev S.G., et al. Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis. J. Neuroimmunol. 2008, 194:132-142.
19. L'Heureux D.Z., et al. The interaction of angiocidin with tissue transglutaminase. Exp. Mol. Pathol. 2010, 88:15-25.
20. Miled C., et al. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. Cancer Res. 2005, 65:5096-5104.
21. Nicolini A., et al. Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006, 17:325-337.
22. Nilsson U.W., et al. Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clin. Cancer Res. 2010, 16:3659-3669.
23. Reed C.C., et al. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005, 24:1104-1110.
24. Roy D., et al. Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front. Biosci. 2006, 11:889-898.
25. Sabherwal Y., et al. Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein. Exp. Cell Res. 2006, 312:2443-2453.
26. Sato K., et al. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 1995, 215:1078-1087.
27. Shyr C.R., et al. Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells. J. Biol. Chem. 2002, 277:14622-14628.
28. Sica G., et al. Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Cancer 1987, 60:2419-2423.
29. Tuszynski G.P., et al. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J. Cell Biol. 1993, 120:513-521.
30. van der Burg B., et al. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endocrinol. 1989, 64:223-228.
31. Walters K.J., et al. Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry 2002, 41:1767-1777.
32. Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 2001, 37(Suppl 4):S3-S8.
33. Zhou J., et al. Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1. J. Cell. Biochem. 2004, 92:125-146.